NO170084C - Analogifremgangsmaate til fremstilling av terapeutisk aktive dihydropyridinderivater - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive dihydropyridinderivater

Info

Publication number
NO170084C
NO170084C NO874219A NO874219A NO170084C NO 170084 C NO170084 C NO 170084C NO 874219 A NO874219 A NO 874219A NO 874219 A NO874219 A NO 874219A NO 170084 C NO170084 C NO 170084C
Authority
NO
Norway
Prior art keywords
group
alkyl
substituent selected
preparation
alkoxy
Prior art date
Application number
NO874219A
Other languages
English (en)
Norwegian (no)
Other versions
NO874219D0 (no
NO170084B (no
NO874219L (no
Inventor
Hiroyuki Koike
Masafumi Yoshimoto
Hiroshi Nishino
Original Assignee
Sankyo Co
Ube Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co, Ube Industries filed Critical Sankyo Co
Publication of NO874219D0 publication Critical patent/NO874219D0/no
Publication of NO874219L publication Critical patent/NO874219L/no
Publication of NO170084B publication Critical patent/NO170084B/no
Publication of NO170084C publication Critical patent/NO170084C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
NO874219A 1986-10-09 1987-10-09 Analogifremgangsmaate til fremstilling av terapeutisk aktive dihydropyridinderivater NO170084C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24025486 1986-10-09

Publications (4)

Publication Number Publication Date
NO874219D0 NO874219D0 (no) 1987-10-09
NO874219L NO874219L (no) 1988-04-11
NO170084B NO170084B (no) 1992-06-01
NO170084C true NO170084C (no) 1992-09-09

Family

ID=17056752

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874219A NO170084C (no) 1986-10-09 1987-10-09 Analogifremgangsmaate til fremstilling av terapeutisk aktive dihydropyridinderivater

Country Status (20)

Country Link
US (1) US4772596A (xx)
EP (2) EP0529702B1 (xx)
JP (1) JPS63253082A (xx)
KR (1) KR920004483B1 (xx)
CN (1) CN1017897B (xx)
AT (2) ATE146169T1 (xx)
AU (1) AU600038B2 (xx)
CA (1) CA1309098C (xx)
DE (2) DE3751978T2 (xx)
DK (1) DK170891B1 (xx)
ES (2) ES2059391T3 (xx)
FI (1) FI90543C (xx)
GR (1) GR3022301T3 (xx)
HK (2) HK1005727A1 (xx)
HU (1) HU199454B (xx)
IE (1) IE63111B1 (xx)
NO (1) NO170084C (xx)
NZ (1) NZ222106A (xx)
RU (1) RU1831476C (xx)
ZA (1) ZA877518B (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671349B1 (fr) * 1991-01-09 1993-04-23 Lafon Labor Nouveaux derives de 1,4-dihydropyridine, leur procede de preparation et composition therapeutique les contenant.
US5310917A (en) * 1991-09-13 1994-05-10 Merck & Co., Inc. Process for the preparation of 4-substituted-1,4-dihydropydrines
RU2239432C2 (ru) * 2000-04-11 2004-11-10 Санкио Компани Лимитед, Убе Индастриз, Лтд. Стабилизированная фармацевтическая композиция, содержащая блокатор кальция
CA2420844A1 (en) * 2000-08-30 2003-02-28 Sankyo Company, Limited Medicinal compositions for preventing or treating heart failure
PL375996A1 (en) * 2002-12-24 2005-12-12 Sankyo Company, Limited Optically active dihydropyridine derivative
JP4546726B2 (ja) * 2002-12-24 2010-09-15 宇部興産株式会社 光学活性なジヒドロピリジン誘導体
EP1604664A4 (en) 2003-01-31 2006-12-27 Sankyo Co MEDICAMENT FOR THE PREVENTION AND TREATMENT OF ARTERIOSCLEROSIS AND BLOOD HIGH PRESSURE
JP4629973B2 (ja) * 2003-09-22 2011-02-09 第一三共株式会社 光学活性シクロプロピルアミン誘導体およびその製造方法
ES2537976T3 (es) 2003-12-12 2015-06-16 Daiichi Sankyo Company, Limited Compuestos intermedios para la producción de derivados de ciclopropilamina ópticamente activos y procedimiento para la producción de los compuestos intermedios
JP2008543862A (ja) * 2005-06-15 2008-12-04 エラン ファーマ インターナショナル リミテッド ナノ粒子アゼルニジピン製剤
JP5148296B2 (ja) * 2005-06-27 2013-02-20 第一三共株式会社 アンジオテンシンｉｉ受容体拮抗剤及びカルシウム拮抗剤含有医薬組成物
CN100352818C (zh) * 2005-09-23 2007-12-05 四川科伦药业股份有限公司 一种改进的制备阿折地平的方法
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
TWI399223B (zh) * 2006-09-15 2013-06-21 Daiichi Sankyo Co Ltd 奧美沙坦酯及氨氯地平之固體劑型
JP2008290988A (ja) * 2007-05-28 2008-12-04 Ube Ind Ltd 光学活性なジヒドロピリジン誘導体の酸付加塩を含有する医薬
JP2008290989A (ja) * 2007-05-28 2008-12-04 Ube Ind Ltd ジヒドロピリジン誘導体の酸付加塩を含有する医薬
IT1391113B1 (it) * 2008-09-30 2011-11-18 Dipharma Francis Srl Procedimento per la preparazione di azelnidipina cristallina
JP5463051B2 (ja) * 2009-02-17 2014-04-09 相模化成工業株式会社 １，４―ジヒドロピリジン誘導体の製造法
CN101863879B (zh) * 2009-04-16 2012-12-19 四川科伦药物研究有限公司 一种α晶型阿折地平的制备方法
JP2011006379A (ja) * 2009-05-26 2011-01-13 Tokuyama Corp ｛２−アミノ−１，４−ジヒドロ−６−メチル−４−（３−ニトロフェニル）−３，５−ピリジンジカルボン酸３−（１−ジフェニルメチルアゼチジン−３−イル）エステル５−イソプロピルエステル｝（アゼルニジピン）の再結晶方法、アゼルニジピンのイソプロピルアルコール付加体、およびアゼルニジピンの製造方法
JP2011105649A (ja) * 2009-11-18 2011-06-02 Daito Kk アゼルニジピンの結晶
JP5637710B2 (ja) * 2010-03-24 2014-12-10 株式会社トクヤマ ｛２−アミノ−１，４−ジヒドロ−６−メチル−４−（３−ニトロフェニル）−３，５−ピリジンジカルボン酸３−（１−ジフェニルメチルアゼチジン−３−イル）エステル５−イソプロピルエステル｝の製造方法
JP2012020970A (ja) * 2010-07-15 2012-02-02 Tokuyama Corp ｛２−アミノ−１，４−ジヒドロ−６−メチル−４−（３−ニトロフェニル）−３，５−ピリジンジカルボン酸３−（１−ジフェニルメチルアゼチジン−３−イル）エステル５−イソプロピルエステル｝の製造方法
EP2703398B1 (en) * 2011-04-29 2017-12-13 Xuanzhu Pharma Co., Ltd. 1,4-dihydropyridine -3,5-dicarboxylate derivatives, preparation methods and uses thereof
JP5917034B2 (ja) * 2011-07-15 2016-05-11 ニプロ株式会社 カルシウムブロッカーを含有する固形医薬組成物
CA2846387C (en) 2011-08-26 2016-02-09 Wockhardt Limited Methods for treating cardiovascular disorders
CN102329259B (zh) * 2011-10-21 2013-09-18 南京工业大学 (1-二苯甲基-3-吖丁啶醇)氰基乙酸酯的制备方法
CN102382104A (zh) * 2011-11-21 2012-03-21 山东新华制药股份有限公司 α晶型阿折地平的制备方法
CN103319457B (zh) * 2012-03-20 2016-01-27 北京晶润宏达医药科技有限公司 阿折地平γ晶型的制备方法
WO2017063307A1 (zh) * 2015-10-13 2017-04-20 山东轩竹医药科技有限公司 1，4-二氢吡啶-3，5-二羧酸酯衍生物的制备方法及中间体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2003146A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
US3935223A (en) * 1972-03-06 1976-01-27 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
GB1455502A (en) * 1973-02-20 1976-11-10 Yamanouchi Pharma Co Ltd 1,4-dihydropyridine derivatives
JPS55301A (en) * 1978-02-14 1980-01-05 Yamanouchi Pharmaceut Co Ltd 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
JPS57171968A (en) * 1981-04-17 1982-10-22 Kyowa Hakko Kogyo Co Ltd 1,4-dihydropyridine derivative
JPS5970666A (ja) * 1982-10-15 1984-04-21 Kyowa Hakko Kogyo Co Ltd １，４−ジヒドロピリジン誘導体
DE3244178A1 (de) * 1982-11-30 1984-05-30 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
EP0125803A3 (en) * 1983-04-27 1987-01-21 FISONS plc Pharmaceutically active dihydropyridines
GB8314744D0 (en) * 1983-05-27 1983-07-06 Fujisawa Pharmaceutical Co 2 6-disubstituted-1 4-dihydropyridine derivative
US4603135A (en) * 1983-10-17 1986-07-29 Takeda Chemical Industries, Ltd. Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates
JPS6289662A (ja) * 1985-06-14 1987-04-24 Sankyo Co Ltd １，４−ジヒドロピリジン誘導体

Also Published As

Publication number Publication date
KR920004483B1 (ko) 1992-06-05
IE63111B1 (en) 1995-03-22
ES2059391T3 (es) 1994-11-16
ZA877518B (en) 1989-06-28
NO874219D0 (no) 1987-10-09
IE872706L (en) 1988-04-09
HK1005726A1 (en) 1999-01-22
US4772596A (en) 1988-09-20
EP0266922A1 (en) 1988-05-11
EP0529702B1 (en) 1996-12-11
NO170084B (no) 1992-06-01
FI90543C (fi) 1994-02-25
DE3751978D1 (de) 1997-01-23
ATE146169T1 (de) 1996-12-15
NZ222106A (en) 1989-12-21
DK529987A (da) 1988-04-10
HU199454B (en) 1990-02-28
FI874451A (fi) 1988-04-10
CN1017897B (zh) 1992-08-19
ATE94162T1 (de) 1993-09-15
FI874451A0 (fi) 1987-10-09
JPH0331715B2 (xx) 1991-05-08
EP0529702A1 (en) 1993-03-03
CN87107150A (zh) 1988-05-04
KR880005078A (ko) 1988-06-27
AU600038B2 (en) 1990-08-02
HUT47268A (en) 1989-02-28
DK170891B1 (da) 1996-03-04
NO874219L (no) 1988-04-11
HK1005727A1 (en) 1999-01-22
EP0266922B1 (en) 1993-09-08
AU7953787A (en) 1988-04-14
DE3751978T2 (de) 1997-07-03
FI90543B (fi) 1993-11-15
DK529987D0 (da) 1987-10-09
JPS63253082A (ja) 1988-10-20
GR3022301T3 (en) 1997-04-30
CA1309098C (en) 1992-10-20
ES2097859T3 (es) 1997-04-16
DE3787346D1 (de) 1993-10-14
RU1831476C (ru) 1993-07-30
DE3787346T2 (de) 1994-04-21

Similar Documents

Publication Publication Date Title
NO170084C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive dihydropyridinderivater
ATE126216T1 (de) Pyrazolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
NO900991D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(l-piperazinyl)-4-fenylcycloalkanopyridin-derivater
NO894299D0 (no) Fremgangsmaate for fremstilling av pyrimidindion-derivater.
DE3873612D1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DK0490566T3 (da) Fremstilling og anvendelse af N-iodpropargyloxycarbonylaminosyreestere og derivater som antimikrobielle midler
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
NO167029C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinkarboksylsyrederivater
DK0485219T3 (da) Lægemidler til forebyggelse og behandling af kredsløbsorgansygdomme indeholdende spiro-3-heteroazolidinforbindelser
KR870000299A (ko) 1,4-디히드로피리딘 유도체의 제조방법
DK455285A (da) 2-pyridin-thiolderivater
DK193090D0 (da) Imidazolyl- og pyridylderivater af phenylsubstituerede 1,4-dihydropyridiner og fremgangsmaade til fremstilling deraf
DK0410343T3 (da) Anvendelse af bisphenolderivater til behandling af diabetes mellitus
DE3782235D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.